Skip to main content
Synergus
Home
About
Our Publications
Employment Opportunities
Intern/Thesis Opportunities
Find Us
Privacy Policy
Contact Us
Subscribe to Synergus RWE News
IGES group
RWE impact
Data that makes the difference
Real World Data / Statistical analysis
Evidence For Decisions
Market Access
Countries
Diagnostics
Digital Health
Medical Device
Market access strategy
Hands-on market access support
Reimbursement dossier / HTA dossier
Reimbursement/DRG analysis
Pharma
HEOR
Health Economics
Cost Effectiveness and Budget Impact Modelling
Economic Outcomes in Clinical Studies
Value Demonstration
Events/Webinars
News
Blog
You are here
Home
»
Blog
Home
About
Our Publications
Employment Opportunities
Intern/Thesis Opportunities
Find Us
Privacy Policy
Subscribe to Synergus RWE News
RWE impact
Data that makes the difference
Real World Data / Statistical analysis
Evidence For Decisions
Market Access
Countries
Diagnostics
Digital Health
Medical Device
Market access strategy
Reimbursement/DRG analysis
Reimbursement dossier / HTA dossier
Hands-on market access support
Pharma
HEOR
Health Economics
Cost Effectiveness and Budget Impact Modelling
Economic Outcomes in Clinical Studies
Value Demonstration
Events/Webinars
News
Blog
News
Blog
Blog posts tagged by "Market Access"
Class IIb and III – Clarify Eligibility for 137 (h) prior to submitting NUB in Germany!
17 Sep 2023
Tags:
Germany
Coverage with Evidence Development
Medical Device
read more
France: Temporary reimbursement pending results from clinical trial
18 Jul 2023
Tags:
France
Coverage with Evidence Development
Medical Device
read more
Medical Device and EU HTA Regulation - Norwegian perspective
09 Jul 2023
Tags:
EU HTAR
EU HTAR Medtech
Norway
Medical Device
read more
Coverage With Evidence Development for Digital Health
11 Jun 2023
Tags:
Digital Health
Coverage with Evidence Development
DHS France
DHS Germany
DHS Belgium
read more
The German NUB process, the most risky process for a start-up?
08 Feb 2022
Tags:
Germany
Coverage with Evidence Development
Innovation Funding
read more
More news
Contact us
Tags
Alzheimer
Artificial Intelligence
Breast cancer
China
Co-payment
Corona virus
Country specific
Coverage with Evidence Development
COVID-19
Data Science in Oncology
Dementia
Denmark
DHS Belgium
DHS France
DHS Germany
Diabetes
Digital Health
Digital Heath Strategies
Disease Specific
EMA
Empowered Patients
EQ-5D
EU HTAR
EU HTAR Medtech
Finland
France
Funding
Germany
Health Economics
Heart Failure
HQRWE_Fracture
HQ_RWD
HTA
Imaging
Innovation Funding
Italy
IVD
Legislation
Lung Cancer
Market Access
Medical Device
Melanoma
Mental Health
Multiple Sclerosis
Myeloma
Netherlands
Norway
Obesity
Oncology
Out-patient procedures
Patient Registries
Pharma
Quality of Life
R-RCT
Real World Data
Real World Evidence
RefugeeMD
Registries
Rheumatoid Arthritis
RWD Scientific Impact
SF-36
Stroke
Sweden
The Netherlands
Throat Cancer
Transferability of Outcomes
United Kingdom
Value Based Healthcare